Page last updated: 2024-08-23

stearoylethanolamide and Obesity

stearoylethanolamide has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gula, NM; Klimashevsky, VM; Kosiakova, GV; Onopchenko, OV; Oz, M1
Berdyshev, AG; Hula, NM; Kosiakova, HV; Onopchenko, OV; Panchuk, RR; Stoika, RS1

Other Studies

2 other study(ies) available for stearoylethanolamide and Obesity

ArticleYear
N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats.
    Lipids, 2015, Volume: 50, Issue:1

    Topics: Animals; Diet, High-Fat; Ethanolamines; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Male; Obesity; Pancreas; Rats; Rats, Sprague-Dawley; Stearic Acids

2015
N-Stearoylethanolamine suppresses the pro-inflammatory cytokines production by inhibition of NF-κB translocation.
    Prostaglandins & other lipid mediators, 2015, Volume: 121, Issue:Pt A

    Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Body Weight; Cell Line, Tumor; Cell Nucleus; Cytokines; Dose-Response Relationship, Drug; Ethanolamines; Insulin; Insulin Resistance; Lipopolysaccharides; Macrophages, Peritoneal; Mice; NF-kappa B; Obesity; Rats; RNA, Messenger; Stearic Acids

2015